Literature DB >> 9575871

Increased lung preproET-1 and decreased ETB-receptor gene expression in fetal pulmonary hypertension.

D D Ivy1, T D Le Cras, M P Horan, S H Abman.   

Abstract

Endothelin (ET)-1, a potent vasoconstrictor and smooth muscle mitogen, is produced from its precursor, preproET-1, by endothelin-converting enzyme (ECE)-1 activity. ET-1 may bind to two receptors, ETA and ETB, that mediate vasoconstriction and vasodilation in the ovine fetal lung, respectively. ET-1 contributes to high pulmonary vascular resistance in experimental perinatal pulmonary hypertension induced by ligation of the ductus arteriosus in the fetal lamb. Physiological studies in this model have demonstrated enhanced ETA- and diminished ETB-receptor activities and a threefold increase in lung immunoreactive ET-1 protein content. We hypothesized that increased ET production and an imbalance in receptor expression would favor vasoconstriction and smooth muscle cell hypertrophy in pulmonary hypertension and may be partially due to alterations in gene expression. To test this hypothesis, we studied lung mRNA expression of preproET-1, ECE-1, and the ETA and ETB receptors in normal and hypertensive fetal lambs. Total RNA was isolated from whole lung tissue in normal late-gestation fetuses (135 +/- 3 days; 147 days = term) and from animals with pulmonary hypertension after ductus arteriosus ligation for 8 days (134 +/- 4 days). Ductus arteriosus ligation increased right ventricular hypertrophy [control 0.56 +/- 0.02 vs. hypertension 0.85 +/- 0.05; right ventricle/(left ventricle + septum); P < 0.05]. Northern blot analysis was performed using cDNA probes and was normalized to the signal for 18S rRNA. We found a 71 +/- 24% increase in steady-state preproET-1 mRNA (P < 0.05) and a 62 +/- 5% decrease in ETB mRNA (P < 0.05) expression in ductus arteriosus ligation. ECE-1 and ETA-receptor mRNA expression did not change. We conclude that chronic intrauterine pulmonary hypertension after ductus arteriosus ligation increases steady-state preproET-1 mRNA and decreases ETB-receptor mRNA without changing ECE-1 mRNA or ETA-receptor mRNA expression. These findings suggest that increased ET-1 production and decreased ETB-receptor expression may contribute to increased vasoconstrictor tone in this experimental model of neonatal pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575871     DOI: 10.1152/ajplung.1998.274.4.L535

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Effect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia.

Authors:  M Kavanagh; B Battistini; S Jean; J Crochetière; L Fournier; J Wessale; T J Opgenorth; R Cloutier; D Major
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction.

Authors:  Birgit Houweling; Daphne Merkus; Oana Sorop; Frans Boomsma; Dirk J Duncker
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

Review 3.  How valid are animal models to evaluate treatments for pulmonary hypertension?

Authors:  Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09       Impact factor: 3.000

4.  NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation.

Authors:  Sergio de Frutos; Rhyannon Spangler; Dominique Alò; Laura V González Bosc
Journal:  J Biol Chem       Date:  2007-04-02       Impact factor: 5.157

Review 5.  Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.

Authors:  Yuansheng Gao; Tianji Chen; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

6.  Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan.

Authors:  C Goissen; L Ghyselen; P Tourneux; G Krim; L Storme; P Bou; Y Maingourd
Journal:  Eur J Pediatr       Date:  2007-08-15       Impact factor: 3.183

7.  Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels.

Authors:  Stéphanie Sauvageau; Eric Thorin; Louis Villeneuve; Jocelyn Dupuis
Journal:  Pulm Pharmacol Ther       Date:  2009-08       Impact factor: 3.410

Review 8.  Role of endothelin in uteroplacental circulation and fetal vascular function.

Authors:  Alexandra Paradis; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

9.  Altered pulmonary artery endothelial-smooth muscle cell interactions in experimental congenital diaphragmatic hernia.

Authors:  Shannon N Acker; Gregory J Seedorf; Steven H Abman; Eva Nozik-Grayck; Katherine Kuhn; David A Partrick; Jason Gien
Journal:  Pediatr Res       Date:  2015-01-12       Impact factor: 3.756

10.  Deoxycorticosterone acetate-salt hypertensive rats display gender-related differences in ET(B) receptor-mediated vascular responses.

Authors:  R C Tostes Passaglia; F L David; Z B Fortes; D Nigro; R Scivoletto; M H Catelli De Carvalho
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.